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Background
Pacemaker/ AICD imaging is currently being done on
patients in the MRI environment. A vigilant team con-
sisting of the (Cardiologist, EP staff, and technologists)
with close patient monitoring and supervision is mak-
ing such an unmentionable procedure a success. How-
ever, is the diagnosis from imaging these patients
adding valuable irrefutable information to merit such a
risk?
Hypothesis
We propose that MRI imaging patients with a pace-
maker is crucial to the existing diagnosis and in some
instances modifies diagnosis and patient management.
Methods
A total of 100 patients were imaged on a GE CV/i
Excite Version 12,1.5 T system (GE, Milwaukee, WI). 17
patients had an AICD, 10 patients had an AICD/Pace-
maker, 5 patients had a single pacemaker lead, 8 REVO
pacemakers and 60 patients had a complete pacemaker
implantation. A specific criteria was followed for all the
patients undergoing this procedure to scrutinize if the
final diagnosis provided additional information in
patient care. A checklist of three questions were
gathered and answered after the final interpretation of
the MRI.
1) Does the diagnosis change?
2) Does the MRI provide additional information to
the existing diagnosis?
3) Does patient management change?
If yes was answered any of the above questions it was
considered that the MRI scan was of value to patient
diagnosis.
Results
All patients completed the procedure with no adverse
events and the pacemaker was interrogated after the
procedure by EP Lab and the Cardiologist. Regarding
the population, of the 100 patients imaged, 71 (71%)
were neurology cases, 24 (24%) were cardiac/vascular
and 5 musculoskeletal(5%).
After reviewing the results from the 71 neurology
cases 17 (24%) out of the 71 showed that the MRI pro-
vided additional information and changed the original
diagnosis and in turn their course of medical treatment.
37 patients (52%) provided additional information and
therefore a total of 54 patients (76%) showed that the
MRI scan was of value to the final diagnosis. 17 (24%)
out of the 71 patients confirmed original diagnosis. The
24 cardiac cases showed in 5 patients (21%) the MRI
provided additional information to change the original
diagnosis and also patient management. 18 (75%)
showed that extra information was gathered and 1 (4%)
confirmed the original diagnosis. In essence, 96% of the
Cardiac population benefited by having this study done.
The 5 musculoskeletal demonstrated that 4 (80%) pro-
vided additional information and 1 (20%) changed
patient management
Conclusions
The use of PM/AICD imaging in MRI remains contro-
versial but with a cautious cardiac team increased confi-
dence in its use is found. Herein, we show that MRI
procedures on carefully selected patients with pace-
makers/AICD’s are beneficial and substantially add
valuable irrefutable information to patient diagnosis and
1Cardiac MRI, Allegheny General Hospital, Pittsburgh, PA, USA
Full list of author information is available at the end of the article
Yamrozik et al. Journal of Cardiovascular Magnetic
Resonance 2015, 17(Suppl 1):T9
http://www.jcmr-online.com/content/17/S1/T9
© 2015 Yamrozik et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
management. We propose that not only are Pace-
makers/AICD’s no longer forbidden in the MRI environ-
ment but they can be markedly efficient with life-
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